Previous Article | Next Article ![]()
Journal of Virology, April 1999, p. 3071-3079, Vol. 73, No. 4
Program in Cell and Molecular
Biology,1 Division of Molecular
Virology,2 and Department of
Pathology,4 Baylor College of Medicine,
Houston, Texas 77030, and Department of Molecular Biology,
Howard Hughes Medical Institute, Princeton University, Princeton, New
Jersey 085443
Received 3 December 1998/Accepted 4 January 1999
Some human adenoviruses are tumorigenic in rodents. Subgroup A and
B human adenoviruses generally induce sarcomas in both male and female
animals, and the gene products encoded within viral early region 1 (E1
region) are both necessary and sufficient for this tumorigenicity. In
contrast, subgroup D human adenovirus type 9 (Ad9) induces
estrogen-dependent mammary tumors in female rats and requires the E4
region-encoded ORF1 oncoprotein for its tumorigenicity.
Considering the established importance of the viral E1 region for
tumorigenesis by adenoviruses, we investigated whether this viral
transcription unit is also necessary for Ad9 to generate mammary
tumors. The nucleotide sequence of the Ad9 E1 region indicated that the
gene organization and predicted E1A and E1B polypeptides of Ad9
are closely related to those of other human adenovirus E1
regions. In addition, an Ad9 E1 region plasmid demonstrated
focus-forming activity in both low-passage-number and established
rat embryo fibroblasts, whereas a large deletion within either the E1A
or E1B gene of this plasmid diminished transforming activity.
Surprisingly, we found that introducing the same
transformation-inactivating E1A and E1B deletions into Ad9 results in
mutant viruses that retain the ability to elicit mammary tumors in
rats. These results are novel in showing that Ad9 represents a unique
oncogenic adenovirus in which the E4 region, rather than the E1
region, encodes the major oncogenic determinant in the rat.
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Early Region 1 Transforming Functions Are
Dispensable for Mammary Tumorigenesis by Human Adenovirus Type
9



*
Corresponding author. Mailing address: Division of
Molecular Virology, Baylor College of Medicine, One Baylor Plaza,
Houston, TX 77030. Phone: (713) 798-3898. Fax: (713) 798-3586. E-mail: rjavier{at}bcm.tmc.edu.
Present address: Department of Genetics, The Salk Institute, La
Jolla, CA 92037.
Present address: St. Joseph Mercy Hospital, Ann Arbor, MI 48106.
§
Present address: Department of Biochemistry, University of
Connecticut Health Center, Farmington, CT 06032.
Present address: Department of Neurosurgery, New York
Hospital-Cornell University Medical College, New York, NY 10021.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»